Carpmaels & Ransford LLP‘s offering is well-equipped to handle disputes across the EPO, UPC and UK courts, as well as to advise its noteworthy client roster on the remit of patent portfolio management matters, as well as related issues. Life sciences, healthcare and pharma inventions are key areas of expertise of the team. At the helm are Hugh Goodfellow, tech and engineering specialist John Brunner who has specialisms in AI, software and electronics in particular, chemistry and pharma expert Matthew Georgiou, biotech specialist Mark Chapman and IP transactional expert Jake Marshall. ’Master strategist’ James Warner is another name to note, as is Edward Oates who has significant experience handling high-value cases before the EPO, and Daniel Wise who has acted in novel matters before the UPC with support from Emily Nikolic.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
‘They are simply the best firm around for handling complex, sensitive and important matters.'
'They offer unmatched quality. What sets them apart is that they combine strategic nous with a deep understanding of the science.’
‘James Warner is a master strategist. Very impressive.'
'Edward Oates is a pleasure to work with. He has a rare and valuable ability to translate scientific insights into effective legal strategies. Edward is always willing to go the extra mile for clients.’
- 'Very strong technical and scientific knowledge with excellent experience and knowledge of EPO procedures (for oppositions, appeals and prosecution).'
- 'Strategically very strong.'
- 'Harvey Adams and Chris Hoggett are very strong practitioners.'
- 'The patent attorney team is composed exclusively of exceptionally skilled individuals, all of which work in teams that together deliver the best possible outcomes.'
- 'Excellent experience working with Emily Nikolic and Daniel Wise. They are exceptionally knowledgeable and bring a high level of expertise. Their flexibility and responsiveness in unchartered waters is nothing short of spectacular. '
- 'The team is absolutely the best choice for EP oppositions by far.'
Key clients
- Sanofi
- Johnson & Johnson
- Novartis
- Janssen Biotech
- Regeneron Pharmaceuticals
- Takeda
- Gilead Sciences
- KalVista Pharmaceuticals
- Vertex Pharmaceuticals
- Bristol Myers Squibb
- bioMérieux
- Barclays Bank PLC
- Abbott
- CSL
- Eli Lilly
- GH Research
- Guardant health
- Hubrecht Organoid Technology
- Incyte Corp
- Ionis Pharmaceuticals
Work highlights
Led the successful client in the first ever UPC revocation decision of the Central Division UPC.
Advised seminal Board of Appeal decisions in our client’s favour following our written and oral advocacy at the EPO.
Coordinated preparation for litigation concerning ELVANSE® across Europe.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Emily Nikolic
Practice head
Hugh Goodfellow; John Brunner; Matthew Georgiou; Mark Chapman; Jake Marshall
Other key lawyers
Harvey Adams; Chris Hoggett; James Warner; Cameron Marshall; Daniel Wise; Edward Oates; Paul Bettridge; Stephen Duffield; Anna Leathley; Ian Kirby; Russell Woolley; Emily Nikolic